AstraZeneca has said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine because of an unexplained illness in a study participant.

The vaccine, developed with the University of Oxford, has been widely seen as one of the leading global candidates against the coronavirus, and the suspension of the trial dims prospects for a potential year-end rollout its lead developer had signalled earlier.

According to Reuters, AstraZeneca said it voluntarily paused trials to allow review of safety data by an independent committee and was working to expedite the review of the single event to minimise any potential impact on the trial timeline.

“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials,” the company said in an emailed statement.

Opinion

The great Covid dole
Updated 04 Mar 2021

The great Covid dole

The government is serving the poor with its words and the rich with its deeds.
Informal sector
04 Mar 2021

Informal sector

Pakistan’s black economy is linked to governance.
The game is on
Updated 03 Mar 2021

The game is on

The PDM appears much more confident despite the fact that it is lacking in numbers.

Editorial

04 Mar 2021

Senate upset

THE Senate election results have delivered a stunning blow to the PTI. While the ruling party has seen an increase ...
04 Mar 2021

ME ‘security pact’

THERE has been an overflowing of bonhomie between the Gulf Arabs and Israel over the past few months, much of it...
04 Mar 2021

Students’ protest

A GROUP of university students in Karachi and Hyderabad caught the media’s attention when they announced a...
Vaccine challenges
Updated 03 Mar 2021

Vaccine challenges

THE last few months have seen several countries rolling out vaccination drives against the novel coronavirus, which...
03 Mar 2021

Rising prices

CONTRARY to government projections and market expectations, the cost of goods and services for the public during...
03 Mar 2021

Myanmar crisis

THE political crisis triggered by the military coup in Myanmar on Feb 1 is worsening, with the generals refusing to...